Education
About Us
Working with TipRanks
Follow Us
Nemaura Medical (NMRD)
:NMRD
NMRD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.02 - $0.10
Previous CloseN/A
Volume1.50K
Average Volume (3M)7.20K
Market Cap
$8.07K
Enterprise ValueN/A
Total Cash (Recent Filing)$10.11M
Total Debt (Recent Filing)$20.03M
Price to Earnings (P/E)―
Beta-421.85
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.38
Shares Outstanding40,351,704
10 Day Avg. Volume8,757
30 Day Avg. Volume7,201
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.10
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Nemaura Medical News
PremiumCompany Announcements
Nemaura Medical: Executive Reshuffle and Strategic Outsourcing
PremiumCompany Announcements
Nemaura Medical Restructures Finances, Board Members ChangePremiumPre-Earnings
Is NMRD a Buy, Before Earnings?
---
Ownership Overview
―
Insiders
2.09% Other Institutional Investors
97.91% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
NMRD FAQ
What was Nemaura Medical’s price range in the past 12 months?
Nemaura Medical lowest stock price was $0.01 and its highest was $0.10 in the past 12 months.
What is Nemaura Medical’s market cap?
Nemaura Medical’s market cap is $8.07K.
When is Nemaura Medical’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nemaura Medical’s earnings last quarter?
Currently, no data Available
Is Nemaura Medical overvalued?
According to Wall Street analysts Nemaura Medical’s price is currently Overvalued.
Does Nemaura Medical pay dividends?
Nemaura Medical does not currently pay dividends.
What is Nemaura Medical’s EPS estimate?
Nemaura Medical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nemaura Medical have?
Nemaura Medical has 40,351,704 shares outstanding.
What happened to Nemaura Medical’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nemaura Medical?
Currently, no hedge funds are holding shares in NMRD
---
Company Description
Nemaura Medical
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
---
NMRD Stock 12 Month Forecast
Average Price Target
―Best Analysts Covering NMRD
1 Year
1 Year Success Rate
0/7 ratings generated profit
1 Year Average Return
-77.89%
reiterated a buy rating a year ago
Copying Edward Woo's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -77.89% per trade.
---